RT Journal Article
T1 Reply to: "Normothermic regional perfusion - What is the benefit?".
A1 Hessheimer, Amelia J
A1 Coll, Elisabeth
A1 Ruíz, Patricia
A1 Gastaca, Mikel
A1 Rivas, Jose Ignacio
A1 Gomez, Manuel
A1 Sanchez, Belinda
A1 Santoyo, Julio
A1 Ramirez, Pablo
A1 Parrilla, Pascual
A1 Marin, Luis Miguel
A1 Gomez-Bravo, Miguel Angel
A1 Garcia-Valdecasas, Juan Carlos
A1 Lopez-Monclus, Javier
A1 Bosca, Andrea
A1 Lopez-Andujar, Rafael
A1 Fundora-Suarez, Yiliam
A1 Villar, Jesus
A1 Garcia-Sesma, Alvaro
A1 Jimenez, Carlos
A1 Rodríguez-Laiz, Gonzalo
A1 Llado, Laura
A1 Rodriguez, Juan Carlos
A1 Barrera, Manuel
A1 Charco, Ramon
A1 Lopez-Baena, Jose Angel
A1 Briceño, Javier
A1 Pardo, Fernando
A1 Blanco, Gerardo
A1 Pacheco, David
A1 Dominguez-Gil, Beatriz
A1 Sanchez Turrion, Victor
A1 Fondevila, Constantino
K1 Liver Transplantation
K1 Perfusion
K1 Tissue and Organ Procurement
AB Wethank Drs. Schlegel, Muiesan, and Dutkowski for their interest in our manuscript1 and are delighted to provide clearer and updated information regarding the use of normothermic regional perfusion (NRP) in controlled donation after circulatory death (cDCD) liver transplantation. Our manuscript describes the Spanish experience with cDCD liver transplantation from national application in 2012 through 2016, comparing outcomes of transplants performed with NRP versus those performed with super rapid recovery (SRR).2 Transplants were included from 20 centers, only 3 (15%) with previous experience performing uncontrolled donation after circulatory death. The results that we present can be achieved by not just perfusion and DCD ‘‘experts” but by virtually any liver transplant team.
PB Elsevier
YR 2019
FD 2019-05-23
LK http://hdl.handle.net/10668/14024
UL http://hdl.handle.net/10668/14024
LA en
NO Hessheimer AJ, Coll E, Ruíz P, Gastaca M, Rivas JI, Gómez M, et al. Reply to: "Normothermic regional perfusion - What is the benefit?". J Hepatol. 2019 Aug;71(2):443-445
DS RISalud
RD May 12, 2025